- Home
- LNKB vs PROF Comparison
LNKB vs PROF Comparison
Compare LNKB & PROF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNKB | PROF |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | | Medical/Dental Instruments |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 310.2M | 270.7M |
| IPO Year | 2022 | 2017 |
Fundamental Metrics
Financial Performance| Metric | LNKB | PROF |
|---|---|---|
| Price | $8.30 | $5.89 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | 91.2K | ★ 354.9K |
| Earning Date | 04-27-2026 | 03-05-2026 |
| Dividend Yield | ★ 3.61% | N/A |
| EPS Growth | ★ 26.76 | 25.89 |
| EPS | 0.90 | ★ 1.41 |
| Revenue | ★ $186,504,000.00 | $16,098,000.00 |
| Revenue This Year | $10.18 | $115.41 |
| Revenue Next Year | $9.33 | $60.63 |
| P/E Ratio | $9.22 | ★ $4.22 |
| Revenue Growth | 11.29 | ★ 50.73 |
| 52 Week Low | $6.09 | $3.90 |
| 52 Week High | $9.59 | $8.95 |
Technical Indicators
Market Signals| Indicator | LNKB | PROF |
|---|---|---|
| Relative Strength Index (RSI) | 45.15 | 47.64 |
| Support Level | $8.07 | $5.81 |
| Resistance Level | $9.02 | $5.98 |
| Average True Range (ATR) | 0.21 | 0.48 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 49.06 | 53.57 |
Price Performance
Historical ComparisonAbout LNKB LINKBANCORP Inc.
Linkbancorp Inc operates in the banking industry. It provides banking services for individuals and businesses such as commercial lending, non-profit banking, treasury management, deposits and loans. Company portfolio segments includes: Agriculture and farmland, Construction, Commercial & industrial, Commercial real estate, Residential real estate, Municipal, customers and Other loans.
About PROF Profound Medical Corp.
Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.